BrightSpring Health Services, Inc. Common Stock
HealthcareNASDAQ:BTSG · NASDAQ Global Select
-$0.54 today
Vol 3.90M · Avg 2.97M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
10.2%
avg -3.3%
ROIC
6.6%
avg 3.1%
ROA
3.0%
avg -0.2%
Analysis
ROE is currently the strongest return metric at 10.2% versus its period average of -3.3%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Jon Rousseau | Chairman, President & Chief Executive Officer | $5.84M | — | 52 | $1.32M | 0.68% |
Jennifer A. Phipps | CFO, Executive VP & Corporate Secretary | $1.44M | — | 45 | $285,224.00 | 0.15% |
Scott Greenwell | Executive VP & President of PharMerica | $864,560.00 | — | — | $49,073.00 | 0.03% |
Lisa Nalley | Chief of Staff & Senior Vice President of Human Resources | $796,251.00 | — | 53 | $166,948.00 | 0.09% |
Mike McMaude | Consultant | $745,274.00 | — | 58 | $207,590.00 | 0.11% |
Jennifer Yowler | Senior VP of Sales & Account Management - PharMerica | $551,515.00 | — | 49 | $285,224.00 | 0.15% |
William Mills | Senior Vice President of Medical Affairs | — | — | — | — | — |
Charles H. Wardrip | Chief Information Officer | — | — | — | — | — |
Daryn Demeritt | Senior Vice President of Government Relations | — | — | — | — | — |
Jeffrey Hopper | Legal Counsel | — | — | — | — | — |
Rachael Kurzer Givens | Chief Compliance Officer | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
17
$4.31B
Net Sentiment
$4.31B
Net selling
Most Active
ROUSSEAU JON B
4 transactions
1–10 of 17
Analysis
Insiders reported 0 buys worth $0.00 and 17 sells worth $4.31B over the last 12 months. That adds up to net selling of $4.31B. ROUSSEAU JON B was the most active insider with 4 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | +19.5% | +17.8% (8yr)5 analysts |
| Net Income | N/A | N/A | N/A | N/A5 analysts |
| EBIT | N/A | N/A | +43.7% | +18.2% (8yr)5 analysts |
Analysis
Recent growth has been strongest in EBIT at +43.7% over three years. Forward estimates point to EBIT at +18.2% (8yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Krystal Biotech, Inc.
NASDAQ:KRYS
$9.38B
Bruker Corporation
NASDAQ:BRKR
$8.19B
HealthEquity, Inc.
NASDAQ:HQY
$7.37B
Teleflex Incorporated
NYSE:TFX
$5.79B
Chemed Corporation
NYSE:CHE
$5.58B
CRISPR Therapeutics AG
NASDAQ:CRSP
$4.82B
Stevanato Group S.p.A.
NYSE:STVN
$4.66B
RadNet, Inc.
NASDAQ:RDNT
$4.50B
Merit Medical Systems, Inc.
NASDAQ:MMSI
$3.95B
iRhythm Technologies, Inc.
NASDAQ:IRTC
$3.70B
Who manages BTSG?
BrightSpring Health Services, Inc. Common Stock (BTSG) lists 11 active executives. The top listed executive is Mike McMaude, Consultant.
Are BTSG insiders buying or selling?
Recent insider activity shows net selling of $1502.83T.
Explore More
Continue the stock analysis
Jump to another research area for this company.